Stockreport

Why Corvus Pharmaceuticals (CRVS) Is Up 211.8% After Upsized Equity Raise On Soquelitinib Phase 2 Plans [Yahoo! Finance]

Corvus Pharmaceuticals, Inc.  (CRVS) 
Last corvus pharmaceuticals, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corvuspharma.com
PDF to severe atopic dermatitis, and moved ahead with plans to start a Phase 2 trial while completing an upsized US$175.00 million follow-on common stock offering. An inte [Read more]